Results

Total Results: 2,212 records

Showing results for "drug".

181. Assessing Harms when Comparing Medical Interventions | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/methods-guidance-harms/methods
     May 01, 2020 - Adverse drug reactions: definitions, diagnosis, and management. … Adverse drug reactions: keeping up to date. … Detection, verification, and quantification of adverse drug reactions. … The Research on Adverse Drug Events and Reports (RADAR) project. … Adverse reaction/adverse drug reaction An adverse effect specifically associated with a drug.

182. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1512.pdf
     December 01, 2015 - drug- name=orkambi. 14. Walker J. FDA panel backs Vertex cystic-fibrosis drug Orkambi. … drug-name=orkambi http://www.wsj.com/articles/fda-panel-backs-vertex-cystic-fibrosis-drug-orkambi-1431462559 … Policy #DRUG.00080. [internet]. … drug- name=pirfenidone. 71. Medica. … National drug list: drug list - three (3) tier drug plan.

183. Medication-Therapy-Management Executive (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/medication-therapy-management_executive.pdf
     November 01, 2014 - - drug interactions or adverse event � Drug therapy problems that are resolved as defined by primary … studies but typically including the following: needed drug initiated; unnecessary drug discontinued … Gurwitz JH, Rochon P, Food and Drug Administration. … Out-of-Bounds: Rising Prescription Drug Prices for Seniors. … Association of Chain Drug Stores Foundation.

184. S44 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s44.pdf
     October 01, 2007 - ARTICLE Designed Delays Versus Rigorous Pragmatic Trials Lower Carat Gold Standards Can Produce Relevant Drug … We simplified the PRT strategy by using designed delays (DD) to evaluate drug policies. … covering the elderly, the poor, and families with high drug expenditures, introduced a drug benefit … Periodic letters on evidence- based drug therapy improves prescribing: a randomized trial. … Randomized controlled trial of a drug policy change by British Columbia PharmaCare.

185. 1. Which patients benefit the most from MTM services? 1.1. Which factors, or combinations of factors, are most predictive of the clinical benefit of MTM services? 1.1.1. Disease factors (e.g., diabetes vs COPD ; multi-morbidity vs single… | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/1-which-patients-benefit-the-most-from-mtm-services-11-which-factors-or-combinations-of-factors-are-most-predictive-of-the-clinical-benefit-of-mtm-services-111-disease-factors-eg-diabetes-vs-copd-multi-morbidity-vs-single-di
     November 01, 2017 - 2.2.What is the optimal timing of MTM services relative to events or diagnosis (e.g., initiation of drug … beneficiaries with 2 or more chronic conditions and high drug expenditures. … Appropriateness for EHC Program Does your question include a health care drug, intervention, device … therapy by including provisions for medication therapy management (MTM) within the Medicare Part D drug … current eligibility criteria limit the inclusion of patients to those with multi-morbidity and high drug

186. Making Healthcare Safer IV: Summary of Findings on Patient Safety Practices and Ratings by a Technical Expert Panel, 2023-2024 | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/summary-findings
     December 01, 2024 - Disease Control and Prevention, Defense Health Agency, Department of Veterans Affairs, and Food and Drug … Computerized Clinical Decision Support To Prevent Medication Errors and Adverse Drug Events 1a. … Whereas the TEP encouraged implementation of CDSS to reduce medication errors and adverse drug events … Reducing Adverse Drug Events Related to Anticoagulant Use in Adults 9a. … CDSS to reduce medication errors and adverse drug events.

187. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1312.pdf
     December 01, 2013 - -based, online aggregator of prescription drug prices listed prices for the drug at about $27,000 per … Available: http://www.vrtx.com/current-projects/drug- candidates/vx-770.html. … Food and Drug Administration (FDA); 2012 Jan 31 [accessed 2012 Feb 22]. [2 p]. … Drug coverage guidelines. [internet]. … Food and Drug Administration (FDA); [accessed 2012 Jun 28]. [2 p].

188. Antipsychotics for the Prevention and Treatment of Delirium: A Systematic Review (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/delirium-research-protocol.pdf
     June 01, 2018 - Currently, there are no medications approved by the Food and Drug Administration for the prevention … antipsychotic drugs cannot be isolated. 7 Comparison • For KQ 1, we will include non-drug … • For KQ 2, we will include non-drug approaches to treating delirium, including placebo, active … Non-drug interventions will be categorized following the scheme developed by Oh and colleagues.19 … Does antipsychotic drug use increase the risk of long term mortality?

189. Obesity (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/obesity_hi_impact.pdf
     April 17, 2012 - Naltrexone/bupropion combination drug is an oral, sustained-release drug intended to fight the body's … Food and Drug Administration (FDA). … Pharmaceutical companies struggle to develop a drug to treat obesity. … Lorcaserin: FDA issues complete response letter for Lorcaserin new drug application. … FDA accepts new drug application filing for Qnexa. [internet].

190. Migraine Protocol-Appendix 20111103 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/migraine_protocol-appendix_20111103.pdf
     November 03, 2011 - Pharmacological classes for migraine prevention Drug, ATC Code* Class of Drug ANTIEPILEPTICS … (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: November 3, 2011 A-2 Drug … (continued) Source: www.effectivehealthcare.ahrq.gov Published Online: November 3, 2011 A-3 Drug … drug management.mp. 2. exp patient care team/ 3. exp delivery of health care, integrated/ 4. … drug surveillance.mp. 10. exp drug monitoring/ 11. 1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10

191. S143 (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/s143.pdf
     October 01, 2007 - Chief among them is the indication for the drug—a patient must have the condition for which the drug … In a randomized drug trial, the allocation of subjects to treatment and control groups at random leads … Seeger, PharmD, DrPH, Ingenix i3 Drug Safety, 950 Winter Street, Suite 3800, Waltham, MA 02451. … by a text search for the drug name. … Drug treatment of lipid disorders. N Engl J Med. 1999;341: 498–511. 6.

192. Dietary-Supplements Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/dietary-supplements_surveillance.pdf
     January 01, 2013 - Tufts University Boston, MA Katharine Lillie, MD Center for Drug Evaluation & Research, Food & Drug … Intermediate cardiovascular efficacy outcomes of cardiovascular drug(s) plus supplement versus drug(s … (drug-drug interactions) In August 2012, FDA reported an association between Lovaza and recurrent … Clinical or intermediate harms with cardiovascular drug(s) plus supplement versus drug(s) plus placebo … Pharmacokinetic outcomes with cardiovascular drug(s) plus supplement versus drug(s) plus placebo, no

193. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1506.pdf
     October 01, 2015 - Available: http://www.vrtx.com/current-projects/drug- candidates/vx-770.html. … Vertex's two-drug cystic fibrosis treatment shows promise. [internet]. … FDA panel backs Vertex cystic-fibrosis drug Orkambi. Wall Str J. 2015 May 12. … National drug list: drug list - three (3) tier drug plan. … HealthPartners PreferredRx: preferred drug list (formulary). [internet].

194. Addressing Knowledge Gaps in Type 2 Diabetes Therapeutics: Comparative Effectiveness and Safety of Oral Antidiabetic Drugs | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/diabetes-oral-drugs-safety-knowledge-gaps/research
     November 01, 2017 - Pharmacoepidemiol Drug Saf 2011;20:36-44. Huizinga MM, Roumie CL, Greevy RA, et al. … Pharmacoepidemiol Drug Saf 2010;19:1108-12. Hung AM, Roumie CL, Greevy RA, et al.

195. PULMONARY with "Discussions" in Exec Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/pulmonary-horizon-scan-high-impact-1412.pdf
     October 01, 2015 - the drug cost. … In November 2014, the company submitted a new drug application to the U.S. … Early success for Kalydeco is just the beginning for Vertex's CF drug. … Food and Drug Administration (FDA). … Vertex's two-drug cystic fibrosis treatment shows promise. [internet].

196. Patient Safety | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/patient-safety?page=0
     April 02, 2025 - Medication Harms in Older Adults Rapid Evidence Product January 16, 2024 Reducing Adverse Drug … September 29, 2023 Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug … September 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug

197. Patient Safety | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/health-topics/patient-safety
     April 02, 2025 - Medication Harms in Older Adults Rapid Evidence Product January 16, 2024 Reducing Adverse Drug … September 29, 2023 Making Healthcare Safer IV: Protocols for High-Risk Drugs: Reducing Adverse Drug … September 7, 2023 Making Healthcare Safer IV: Prevention of Transmission of Infection With Multi-Drug

198. Summary Variables in Observational Research: Propensity Scores and Disease Risk Scores | Effective Health Care (EHC) Program
     effectivehealthcare-admin.ahrq.gov/products/observational-research-scores/research
     January 01, 2019 - If a patient has high cholesterol and is on other medications, then the potential for drug-drug interactions … For example, perhaps an adverse effect of a drug is only apparent when the drug is prescribed to people … Pharmacoepidemiol Drug Saf 2005;14:S22-3. Figure 5. … Pharmacoepidemiol Drug Safety 2005;14(7):465-76. … Pharmacoepidemiol Drug Saf 2005;14:S21.

199. Management of Suspected Opioid Overdose With Naloxone by Emergency Medical Services Personnel - Executive Summary (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-193-naloxone-executive-summary.pdf
     November 01, 2017 - Food and Drug Administration. 2016 Meeting Materials, Anesthetic and Analgesic Drug Products Advisory … Joint meeting of the anesthetic and analgesic drug products advisory committee and the drug safety and … Joint meeting of the anesthetic and analgesic drug products and the drug safety and risk management … Food and Drug Administration. … Joint meeting of anesthetic and analgesic drug products advisory committee and drug safety and risk

200. Epilepsy-Medicine Surveillance (pdf file)
     effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
     August 01, 2012 - evaluations and one search capturing older versus newer antiepileptic drug evaluations. … Comparative efficacy of combination drug therapy in refractory epilepsy. … Antiepileptic drug combinations--have newer agents altered clinical outcomes? … Pharmacotherapy:The Journal of Human Pharmacology & Drug Therapy. 2012 Apr;32(4):314-22. … drug therapy.fs. 6. randomly.ab. 7. trial.ab. 8. groups.ab. 9.